Coegin Pharma (NGM:COEGIN) Operating Margin %: -1,628.08% (As of Mar. 2026)


NGM:COEGIN Coegin Pharma NGM:COEGIN
30 GF Score
Price kr3.37
! 2 Warning Signs
View Full Analysis

What is Coegin Pharma Operating Margin %?

Coegin Pharma NGM:COEGIN -1.75% 30 Operating Margin % is -1,628.08% as of Mar. 2026. GuruFocus rates NGM:COEGIN with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, Coegin Pharma ranks worse than 89.95% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Coegin Pharma's Operating Income for the three months ended in Mar. 2026 was kr-4.75 Mil. Coegin Pharma's Revenue for the three months ended in Mar. 2026 was kr0.29 Mil. Therefore, Coegin Pharma's Operating Margin % for the quarter that ended in Mar. 2026 was -1,628.08%.

The historical rank and industry rank for Coegin Pharma's Operating Margin % or its related term are showing as below:

NGM:COEGIN' s Operating Margin % Range Over the Past 10 Years
Min: -26842.86   Med: -184.26   Max: -26.25
Current: -5279.41


NGM:COEGIN's Operating Margin % is ranked worse than
89.95% of 945 companies
in the Biotechnology industry
Industry Median: -86.89 vs NGM:COEGIN: -5279.41

Coegin Pharma's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Coegin Pharma's Operating Income for the three months ended in Mar. 2026 was kr-4.75 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was kr-19.58 Mil.


Coegin Pharma  (NGM:COEGIN) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Coegin Pharma Operating Margin % Related Terms


Coegin Pharma Operating Margin % Historical Data

* Premium members only.

The historical data trend for Coegin Pharma's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coegin Pharma Operating Margin % Chart

Coegin Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 -25,889.87

Coegin Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -8,679.75 -1,628.08

NGM:COEGIN vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Coegin Pharma's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coegin Pharma Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coegin Pharma's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Coegin Pharma's Operating Margin % falls into.


NGM:COEGIN
30GF Score
Coegin Pharma NGM:COEGIN
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coegin Pharma Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Coegin Pharma's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-20.453 / 0.079
=-25,889.87 %

Coegin Pharma's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-4.754 / 0.292
=-1,628.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -1,628.08% mean?
Coegin Pharma (NGM:COEGIN) has a Operating Margin % of -1,628.08% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Coegin Pharma and its competitors. According to the industry distribution chart, Coegin Pharma ranks #850 out of 945 companies in the Biotechnology industry, placing it in the top 89.9%.
Is Coegin Pharma's Operating Margin % too high?
Coegin Pharma's current Operating Margin % is -1,628.08%. Based on the distribution chart, Coegin Pharma ranks #850 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Coegin Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Coegin Pharma's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Coegin Pharma ranks #850 out of 945 companies for Operating Margin %. This places Coegin Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Coegin Pharma and its competitors. Coegin Pharma's current Operating Margin % is -1,628.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coegin Pharma stock overvalued right now?
Coegin Pharma (NGM:COEGIN) has a current Operating Margin % of -1,628.08%. The current Operating Margin % is -1,628.08%. Coegin Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Coegin Pharma (NGM:COEGIN), the current Operating Margin % is -1,628.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coegin Pharma Business Description

Other Exchanges 7Z6:Germany
Address c/o Medicon Village, Lund, SWE, 223 81
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
30GF Score

Get the complete analysis for NGM:COEGIN

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.37
Price